Building upon Stéphanie Le Breton’s previous experience in the clinical trial of the early phases of pharmaceutical products and more specifically in the fields of the Central Nervous System and Oncology, SLB Pharma works with companies from the pharmaceutical industry in the clinical development of the medicines of tomorrow.
SLB Pharma offers to manage your clinical project on a national or European scale, either in its entirety or in part, from its design to the processing of data, regardless of the classification:
Intervention research: phase II-IV studies (tolerance, efficacy),
Non-intervention research: observational studies, evaluation of care practices, etc.
